Boston, MA, 30 April 2001 -- Perceptive Informatics, Inc. a division of PAREXEL International (Nasdaq: PRXL) announced today the appointment of Kurt J. Norris as Vice President and Chief Financial Officer. In this role, Mr. Norris will be responsible for guiding the growth and profitability of Perceptive Informatics. In addition, Chris W. Couch has joined Perceptive Informatics as Vice President of e-Services. Mr. Couch will be responsible for overseeing Perceptive's Voice and Data Group, including interactive voice response systems (IVRS) and electronic data capture tools as well as the Web Solutions Group, which manages the delivery of a range of web-based solutions.

Mr. Norris brings to Perceptive Informatics 15 years of experience guiding organizations through periods of rapid growth and development. He joins Perceptive with a depth of experience from the healthcare, financial services and building materials industries. Most recently, he served as a Financial Advisor and Consultant assisting management teams in technology and healthcare related industries. Prior to becoming a consultant, Mr. Norris held leadership positions in finance with Primecare International, Inc. and Caremark International, Inc.

Mr. Couch is an experienced high-technology executive with software consulting and healthcare information technology experience. Most recently, Mr. Couch was Vice President of Distribution at CareTools, Inc. where he was responsible for accelerating the development of Internet based products and for developing relationships with third parties involved in the implementation of health care solutions. Prior to assuming this role, he was Vice President of Operations at CareTools, Inc. and served as Vice President at Symmetrix, Inc.

"The addition of Kurt and Chris to Perceptive's senior management team is an exciting step for Perceptive," said Mark A. Goldberg, M.D., President of Perceptive Informatics, Inc. "Perceptive will benefit from their extensive knowledge of the healthcare industry and hi-tech business as we continue to develop and build solutions that improve information and knowledge management processes for our clients."

Perceptive Informatics, Inc. develops and offers a portfolio of sophisticated and innovative technology-based products and services that facilitate clinical drug development and decrease time to peak sales. The technology portfolio includes web-based portal solutions, Interactive Voice Response Systems (IVRS), electronic data capture, and electronic diary solutions. Perceptive also offers advanced medical diagnostics services to assess rapidly and objectively the safety and efficacy of new drugs, biologics, and medical devices in clinical trials. The Company is headquartered near Boston, MA with approximately 150 employees in offices located throughout North America and Europe. Perceptive Informatics is a subsidiary of PAREXEL International Corporation ("PRXL"), one of the largest contract pharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries.

This release may contain "forward-looking" statements regarding future results and events, including statements regarding expected financial results, future growth and customer demand that involve a number of risks and uncertainties. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes", "anticipates", "plans", "expects", "intends", "appears" and similar expressions are intended to identify forward-looking statements. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the cancellation, revision, or delay of contracts, including those contracts in backlog; the Company's dependence on certain industries and clients; the Company's ability to manage growth and its ability to attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; government regulation of certain industries and clients; competition and consolidation within the pharmaceutical industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Form 10-Q for the period ended December 31, 2000, as filed with the Securities and Exchange Commission.